Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 5, 2002, Pages 973-978

  Fiser, Steven M ^a   Tribble, Curtis G ^a   Kaza, Aditya K ^a   Long, Stewart M ^a   Kern, John A ^a   Cassada, David C ^a   Linden, Joel ^a   Rieger, Jayson ^a   Laubach, Victor E ^a   Matisoff, Andy ^a   Kron, Irving L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; MYELOPEROXIDASE; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; PEROXIDASE; PURINE DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRY WEIGHT; FEMALE; FLOW KINETICS; FLOW RATE; INSPIRATORY CAPACITY; LEUKOCYTE ACTIVATION; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RABBIT; RECEPTOR UPREGULATION; REPERFUSION INJURY; ANIMAL; BLOOD PRESSURE; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; LUNG; LUNG WEDGE PRESSURE; METABOLISM; ORGAN SIZE; PATHOLOGY; REPERFUSION; TIME;

ANIMALS; BLOOD PRESSURE; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; LUNG; MALE; ORGAN SIZE; PEROXIDASE; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; PURINES; RABBITS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; REPERFUSION; REPERFUSION INJURY; TIME FACTORS;

EID: 0036826886     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.124886     Document Type: Article

References (27)

1. Burdine J, Hertz MI, Snover DC, Bolman RM. Heart-lung and lung transplantation: Perioperative pulmonary dysfunction. Transplant Proc. 1991;23:1176-7.
2. Novick RJ, Gehman KE, Ali IS, Lee J. Lung preservation: The importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg. 1996;62:302-14.
3. McGregor CG, Daly RC, Peters SG, Midthun DE, Scott JP, Allen MS, et al. Evolving strategies in lung transplantation for emphysema. Ann Thorac Surg. 1994;57:1513-21.
4. Bando K, Paradis IL, Komatsu K, Konishi H, Matshushima M, Keena RJ, et al. Analysis of time-dependent risks for infection, rejection and death after pulmonary transplantation. J Thorac Cardiovasc Surg. 1995;109:49-59.
5. Breda MA, Hall TS, Stuart S, Baumgartner WA, Borkon AM, Brawn JD, et al. Twenty-four hour lung preservation by hypothermia and leukocyte depletion. J Heart Transplant. 1985;4:325-9.
6. King RC, Binns OAR, Rodriguz F, Kanithanon RC, Daniel TM, Spotnitz WD, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg. 2000;69:1681-5.
7. Aeba R, Griffith BP, Hardesty RL, Kormos RL, Armitage JM. Isolated lung transplantation for patients with Eisenmenger's syndrome. Circulation 1993;88(suppl):452-5.
8. Bando K, Keenan RJ, Paradis IL, Konishi H, Komatsu K, Hardesty RL, et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg. 1994;58:1336-42.
9. Pasque MK, Kaiser LR, Dresler CM, Trulock E, Triantafillou AN, Cooper JC. Single lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1992;103:475-82.
10. Kramer MR, Marshall SE, McDougall MR, Kloneck A, Starnes VA, Lewiston NJ, et al. The distribution of ventilation and perfusion after single-lung transplantation in patients with pulmonary fibrosis and pulmonary hypertension. Transplant Proc. 1991;23(suppl):1215-6.
11. Eppinger MJ, Jones ML, Deeb GM, Bolling SF, Deeb GM. Pattern of injury and the role of neutrophils in reperfusion injury of the rat lung. J Surg Res. 1995;58:713-8.
12. Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia reperfusion injury of rat lung. Am J Pathol. 1997;150:1773-84.
13. Schueler S, DeValeria PA, Hatanaka M, Cameron DE, Bando K, Zeebly M, et al. Successful twenty-four hour lung preservation with donor cooling and leukocyte depletion in an orthotopic double lung transplant model. J Thorac Cardiovasc Surg. 1992;104:73-82.
14. Uthoff K, Zehr KJ, Lee PC, Low RA, Baumgartner WA, Cameron DE, et al. Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation. Ann Thorac Surg. 1995;59:7-13.
15. Ross SD, Tribble CG, Gaughen JR Jr, Shockey KS, Parrino PE, Kron IL. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann Thorac Surg. 1999;67:1428-34.
16. Cronstein BN, Daguma L, Nichols D, Hutchinsosn AJ, Williams M. The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest. 1990;85:1150-7.
17. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissman G. Neutrophil adherence to endothelium is enhancd via adenosine Al receptors and inhibited via adenosine A2 receptors. J Immunol. 1992;148:1041-54.
18. Mullane K, Bullough D. Harnessing and endogenous cardioprotctive mechanism: Cellular sources and sites of action of adenosine. J Mol Cell Cardiol. 1995;27:1041-54.
19. Nolte D, Lorenzen A, Lehr H, Zimmer F, Klotz K, Messmer K. Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor. Naunyn Schmiedebergs Arch Pharmacol. 1992;346:234-7.
20. Bullough DA, Magill MJ. Firestein GS, Mullane KM. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J Immunol. 1995;155:2579-86.
21. Marts BC, Baudendistel LJ, Naunheim KS, Dahms TE. Protective effect of 2-chloroadenosine on lung ischemia-reperfusion injury. J Surg Res. 1993;54:523-9.
22. Lozza G, Conti A, Ongini E, Monopoli A. Cardioprotective effects of adenosine A1 and A2 receptor agonists in the isolated rat heart. Pharmacol Res. 1997;35:57-64.
23. Kaminski PM, Proctor KG. Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine. Circ Res. 1989;65:426-35
24. Todo S, Zhu Y, Zhang S, Jin MB, Ishizaki N, Tanaka H, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation. 1997;63:217-23.
25. Sullivan GW, Linden J, Buster BL, Scheld WM. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: Synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis. 1999;180:1550-60.
26. Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Kron IL. Pulmonary macrophages are involved reperfusion injury after lung transplantation. Ann Thorac Surg. 2001;71:1134-9.
27. Fiser SM, Kron IL, Cassada DC, Long SM, Kaza AK, Kern JA, Tribble CG. Controlled perfusion decreases lung transplant reperfusion injury in the setting of high flow reperfusion. J Heart Lung Transplant. 2002;21:687-91.